SPOTLIGHT: Accelerator launches fourth biotech venture

Seattle-based Accelerator has launched a new blood diagnostic company. The biotech says it can develop new diagnostic techniques for the early diagnosis of disease. This is the fourth biotech venture to come out of the incubator. Article

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.